Leukoplakia and frequency therapy

Definition:

Leukoplakia is a condition characterised by the appearance of white, non-wipeable patches or plaques on the mucous membranes, particularly in the mouth. These lesions are potentially precancerous, which means that in some cases they can develop into .

Causes:

The exact cause of leukoplakia is not fully understood, but several factors may increase the risk:

Tobacco use: smoking and chewing tobacco are the most common risk factors.
Alcohol consumption: Excessive alcohol consumption can increase the risk.
Chronic irritation: Ill-fitting dentures, sharp teeth or other mechanical irritants.
Human papillomavirus (HPV): Some studies have shown a link between HPV and leukoplakia.

Symptoms:

White or grey patches in the mouth that cannot be wiped off.
The patches may be flat or slightly raised and have a rough or leathery texture.
Usually painless, but may be sensitive to touch or spicy foods.

Diagnosis:

Clinical examination: Visual inspection of the oral cavity by a dentist or doctor.
Biopsy: Removal of a tissue sample for histological examination to rule out dysplasia or cancer.

Treatment:

Elimination of risk factors:
Cessation of tobacco and alcohol consumption, adjustment of dentures or treatment of mechanical irritation.
Monitoring:
Regular check-ups to observe changes in the lesions.
Surgical removal:
In some cases, removal of the lesions may be necessary, especially if dysplasia is detected.

Prevention:

Avoidance of tobacco and excessive alcohol consumption.
Regular dental examinations for early detection of changes in the oral mucosa.
Good oral hygiene and care of dentures.

Worth knowing:

Not all white patches in the mouth are leukoplakia; other conditions such as oral candidiasis (oral thrush) can cause similar symptoms.
Although many cases of leukoplakia remain benign, regular monitoring is important to ensure early detection and treatment of potential malignant changes.

Research:

Research is focused on understanding the molecular mechanisms that lead to the development of leukoplakia and developing strategies for prevention and treatment to minimise the risk of malignant transformation.